Tufts University

New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021) Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, et al. Journal article Reactive astrocyte nomenclature, definitions, and future directions (2021) Escartin C, Galea E, Lakatos A, O’Callaghan JP, Petzold GC, Serrano-Pozo A, Steinhäuser C, et al. Journal article, Review article Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021) Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, et al. Journal article Characteristics of p.Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank. (2021) Zebardast N, Sekimitsu S, Wang J, Elze T, Gharahkhani P, Cole BS, Lin MM, et al. Journal article Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop. (2021) Cho Y, Tong A, Craig JC, Mustafa RA, Chapman A, Perrone RD, Ahn C, et al. Journal article Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studies (2021) Ma SC, Tang XR, Long LL, Bai X, Zhou J, Duan ZJ, Wang J, et al. Journal article Abstract: Maximum A-posteriori Signal Recovery for OCT Angiography Image Generation (2021) Husvogt L, Ploner S, Chen S, Stromer D, Schottenhamml J, Alibhai Y, Moult E, et al. Conference contribution Molekularpathologie bei urologischen Tumoren: Empfehlungen der Konsenskonferenz der Internationalen Gesellschaft für Uropathologie (ISUP) 2019 (2021) Hommerding O, Allory Y, Argani P, Bismar TA, Bubendorf L, Canete-Portillo S, Chaux A, et al. Journal article, Review article Longitudinally Assessed Structural Abnormalities on MRI and Relative Contributions to Risk of Incident Radiographic Knee Osteoarthritis over 10 Years of Follow-up (2020) Kwoh CK, Guermazi A, Ashbeck E, Hu C, Bedrick E, Sharma L, Eaton C, et al. Conference contribution Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety (2020) Markman JD, Bolash RB, Mcalindon TE, Kivitz AJ, Pombo-Suarez M, Ohtori S, Roemer F, et al. Journal article